Theravance Biopharma (TBPH) EPS (Basic) (QoQ) (2013 - 2026)
Theravance Biopharma (TBPH) EPS (Basic) (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.02% |
| Dec 31, 2025 | 695.67% |
| Sep 30, 2025 | -93.45% |
| Jun 30, 2025 | 500.03% |
| Mar 31, 2025 | 14.06% |
| Dec 31, 2024 | -22.76% |
| Sep 30, 2024 | 23.63% |
| Jun 30, 2024 | -40.36% |
| Mar 31, 2024 | -151.93% |
| Dec 31, 2023 | 43.90% |
| Sep 30, 2023 | 38.07% |
| Jun 30, 2023 | 19.91% |
| Mar 31, 2023 | -751.27% |
| Dec 31, 2022 | -99.57% |
| Sep 30, 2022 | 4,994.73% |
| Jun 30, 2022 | 16.29% |
| Mar 31, 2022 | -44.17% |
| Dec 31, 2021 | 32.54% |
| Sep 30, 2021 | 47.69% |
| Jun 30, 2021 | 79.53% |